Investigation of the Mechanism for Abnormal Renal 25 Hydroxyvitamin D3-1-Hydroxylase Activity in the XLinkedHypMouse*
- 1 August 1984
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 115 (2) , 634-639
- https://doi.org/10.1210/endo-115-2-634
Abstract
Renal mitochondria from mutant hypophosphatemic male mice (Hyp/Y) fed a vitamin D-deficient, low Ca diet synthesize significantly less 1,25-dihydroxyvitamin D3 than mitochondria from normal male (+/Y) littermates on the same diet. Kinetic studies reveal that maximum velocity (Vmax) for 25-hydroxyvitamin D3-1-hydroxylase (1-hydroxylase) is lower in Hyp/Y relative to +/Y mice (0.21 .+-. 0.02 vs. 1.06 .+-. 0.12 pmol/mg protein .cntdot. min) whereas the apparent Km for the reaction is not different in both genotypes (0.55 .+-. 0.05 vs. 0.50 .+-. 0.08 .mu.M). The presence of an inhibitor for 1-hydroxylase activity in renal mitochondria of Hyp/Y mice was ruled out by estimating enzyme activity in mixtures of renal mitochondria from +/Y and Hyp/Y mice. Phosphate in the incubation medium stimulated 1-hydroxylase activity in +/Y mitochondria. In Hyp/Y mice, the stimulation achieved was smaller in magnitude and the added phosphate did not restore mutant 1-hydroxylase activity to norm. The vitamin D-deficient, low Ca diet led to a significant and comparable increase in serum parathyroid hormone [PTH] and urinary excretion of cAMP in +/Y and Hyp/Y, suggesting that the mutant strain had an approprimate PTH response to the diet-induced fall in serum Ca. The fractional excretion index of phosphate which is significantly greater in Hyp/Y than +/Y mice which fed the control diet increased 3-fold in both genotypes fed the vitamin D-deficient, low Ca diet. The abnormal renal 1-hydroxylase response in Hyp mice may not be the result of generalized renal resistance to PTH in the mutant strain and the defect in Hyp/Y mice may reside at a regulatory step subsequent to cAMP production.This publication has 14 references indexed in Scilit:
- Ternary solvent mixtures for improved resolution of hydroxylated metabolites of vitamin D2 and vitamin D3 during high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Abnormal Vitamin D Metabolism in the X-Linked Hypophosphatemic Mouse*Endocrinology, 1980
- Evaluation of a Role for 1,25-Dihydroxyvitamin D3 in the Pathogenesis and Treatment of X-linked Hypophosphatemic Rickets and OsteomalaciaJournal of Clinical Investigation, 1980
- Kinetic behavior of 25-hydroxyvitamin D-1-hydroxylase and -24-hydroxylase in rat kidney mitochondria.Journal of Biological Chemistry, 1979
- Hormone-sensitive adenylate cyclase along the nephron of genetically hypophosphatemic miceKidney International, 1979
- Serum 1,25-Dihydroxyvitamin D Levels in Normal Subjects and in Patients with Hereditary Rickets or Bone DiseaseNew England Journal of Medicine, 1978
- A biochemical model for the ionic control of 25-hydroxyvitamin D3 1alpha-hydroxylase.Journal of Biological Chemistry, 1978
- In VivoEvidence for the Intermediary Role of 3′,5′-Cyclic AMP in Parathyroid Hormone-Induced Stimulation of lα,25-Dihydroxy vitamin D3Synthesis in RatsEndocrinology, 1977
- The Importance of Phosphate in Regulating Plasma 1,25-(OH)2-Vitamin D Levels in Humans: Studies in Healthy Subjects, in Calcium-Stone Formers and in Patients with Primary Hyperparathyroidism*Journal of Clinical Endocrinology & Metabolism, 1977
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951